Core Viewpoint - MetLife, Inc. (NYSE:MET) is viewed positively by Wall Street despite mixed fiscal Q3 2025 results, with analysts maintaining Buy ratings while adjusting price targets downward [1][2]. Financial Performance - For fiscal Q3 2025, MetLife reported a revenue decrease of 5.85% year-over-year to $17.36 billion, missing expectations by $789.2 million [2]. - The earnings per share (EPS) of $2.37 exceeded estimates by $0.05, indicating strong performance in this area [2][3]. Management Insights - The revenue decline was attributed to significant net investment losses of $325 million and net derivative losses of $929 million [3]. - Despite these losses, adjusted earnings per share increased by 21%, supported by strong variable investment income, broad-based volume growth, and effective expense management [3]. Company Overview - MetLife, Inc. is a global financial services company that offers insurance, annuities, employee benefits, and asset management services to both individual and institutional customers [4].
Wall Street Has a Positive Outlook on MetLife, Inc. (MET)